Progression of actinic keratosis to squamous cell carcinoma revisited: Clinical and treatment implications

Cutis

Volumn 87, Issue 4, 2011, Pages 201-207

  Feldman, Steven R ^a   Fleischer Jr , Alan B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC KERATOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; PATHOLOGY; PRECANCER; REVIEW; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; KERATOSIS, ACTINIC; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS;

EID: 79960945313     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Karagas MR, Zens MS, Nelson HH, et al. Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damage [published online ahead of print January 4, 2007]. Am J Epidemiol. 2007;165:719-726.
2. Kennedy C, Bajdik CD, Willemze R, et al; Leiden Skin Cancer Study. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol. 2003;120:1087-1093.
3. Engel A, Johnson ML, Haynes SG. Health effects of sunlight exposure in the United States: results from the first National Health and Nutrition Examination survey, 1971-1974. Arch Dermatol. 1988;124:72-79.
4. Chen GJ, Feldman SR, Williford PM, et al. Clinical diagnosis of actinic keratosis identifies an elderly population at high risk of developing skin cancer. Dermatol Surg. 2005;31:43-47.
5. Drake LA, Ceilley RI, Cornelison RL, et al. Guidelines of care for actinic keratoses. committee on guidelines of care. J Am Acad Dermatol. 1995;32:95-98.
6. Lober BA, Lober CW. Actinic keratosis is squamous cell carcinoma. South Med J. 2000;93:650-655.
7. Stulberg DL, Crandell B, Fawcett RS. Diagnosis and treatment of basal cell and squamous cell carcinomas. Am Fam Physician. 2004;70:1481-1488.
8. Caro WA, Bronstein BR. Tumors of the skin. In: Moschella SL, Hurley HJ, eds. Dermatology. 2nd ed. Philadelphia, PA: WB Saunders Co; 1985:1533-1638.
9. Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol. 2000;42(1, pt 2):11-17.
10. Anwar J, Wrone DA, Kimyai-Asadi A, et al. The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes. Clin Dermatol. 2004;22:189-196.
11. Ackerman AB, Mones JM. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol. 2006;155:9-22.
12. Roewert-Huber J, Stockfleth E, Kerl H. Pathology and pathobiology of actinic (solar) keratosis-an update. Br J Dermatol. 2007;157(suppl 2):18-20.
13. Curran RC. Skin. In: Curran RC. Color Atlas of Histopathology. 3rd ed. New York, NY: Oxford University Press; 1985:252-279.
14. Harvey I, Frankel S, Marks R, et al. Non-melanoma skin cancer and solar keratoses II analytical results of the South Wales skin cancer study. Br J Cancer. 1996;74:1308-1312.
15. Frost CA, Green AC, Williams GM. The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia). Br J Dermatol. 1998;139:1033-1039.
16. Berman B, Bienstock L, Kuritzky L, et al. Actinic keratoses: sequelae and treatments. recommendations from a consensus panel. J Fam Pract. 2006;55(suppl):1-8.
17. Hemminki K, Zhang H, Czene K. Time trends and familial risks in squamous cell carcinoma of the skin. Arch Dermatol. 2003;139:885-889.
18. Green A, Beardmore G, Hart V, et al. Skin cancer in a Queensland population. J Am Acad Dermatol. 1988;19:1045-1052.
19. Queille S, Luron L, Spatz A, et al. Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene [published online ahead of print October 25, 2006]. Carcinogenesis. 2007;28:724-731.
20. Berner A. Actinic keratosis and development of cutaneous squamous cell carcinoma [in Norwegian]. Tidsskr Nor Laegeforen. 2005;125:1653-1654.
21. Mittelbronn MA, Mullins DL, Ramos-Caro FA, et al. Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol. 1998;37:677-681.
22. Carag HR, Prieto VG, Yballe LS, et al. Utility of step sections: demonstration of additional pathological findings in biopsy samples initially diagnosed as actinic keratosis. Arch Dermatol. 2000;136:471-475.
23. Rigel DS, Friedman RJ, Kopf AW. Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5. J Am Acad Dermatol. 1996;35:1012-1013.
24. Marks R, Foley P, Goodman G, et al. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol. 1986;115:649-655.
25. Rubin E, Farber JL. Neoplasia. In: Rubin E, Farber JL, eds. Pathology. Philadelphia, PA: JB Lippincott Co; 1988:140-195.
26. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1:795-797.
27. Dodson JM, DeSpain J, Hewett JE, et al. Malignant potential of actinic keratoses and the controversy over treatment. a patient-oriented perspective. Arch Dermatol. 1991;127:1029-1031.
28. Harvey I, Frankel S, Marks R, et al. Non-melanoma skin cancer and solar keratoses. I. methods and descriptive results of the South Wales skin cancer study. Br J Cancer. 1996;74:1302-1307.
29. Foote JA, Harris RB, Giuliano AR, et al. Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults. Int J Cancer. 2001;95:7-11.
30. Fuchs A, Marmur E. The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma. Dermatol Surg. 2007;33:1099-1101.
31. Montgomery H, Dorffel J. Verruca senilis und Keratoma senile [in German]. Arch Dermatol Syphilol (Berlin). 1939;39:387-408.
32. Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42(1, pt 2):23-24.
33. Jorizzo J, Dinehart S, Matheson R, et al. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head [published online ahead of print May 18, 2007]. J Am Acad Dermatol. 2007;57:265-268.
34. Ostertag JU, Quaedvlieg PJ, Neumann MH, et al. Recurrence rates and long-term follow-up after laser resurfacing as a treatment for widespread actinic keratoses on the face and scalp. Dermatol Surg. 2006;32:261-267.
35. Fowler JF Jr, Zax RH. Aminolevulinic acid hydrochloride with photodynamic therapy: efficacy outcomes and recurrence 4 years after treatment. Cutis. 2002;69(suppl 6):2-7.
36. Gupta AK. The management of actinic keratoses in the United States with topical fluorouracil: a pharmacoeconomic evaluation. Cutis. 2002;70:30-36.
37. Lawrence N, Cox SE, Cockerell CJ, et al. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol. 1995;131:176-181.
38. Lee PK, Harwell WB, Loven KH, et al. Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream. Dermatol Surg. 2005;31:659-664.
39. Balkrishnan R, Cayce KA, Kulkarni AS, et al. Predictors of treatment choices and associated outcomes in actinic keratoses: results from a national physician survey study. J Dermatol Treat. 2006;17:162-166.
40. Stockfleth E, Sterry W, Carey-Yard M, et al. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. Br J Dermatol. 2007;157(suppl 2):41-46.
41. de Berker D, McGregor JM, Hughes BR; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol. 2007;156:222-230.
42. Szeimies RM, Bichel J, Ortonne JP, et al. A phase II dose-ranging study of topical resiquimod to treat actinic keratosis. Br J Dermatol. 2008;159:205-210.
43. Hampson P, Wang K, Lord JM. PEP-005: treatment of actinic keratosis, acute myeloid leukemia therapy, treatment of basal cell carcinoma, protein kinase C activator. Drugs Fut. 2005;30:1003-1005.
44. Siller G, Gebauer K, Welburn P, et al. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study. Australas J Dermatol. 2009;50:16-22.
45. Hanke CW, Swanson N, Bruce S, et al. Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream. J Drugs Dermatol. 2011;10:165-170.
46. Quist SR, Gollnick HP. Imiquimod 3.75% cream (Zyclara)for the treatment of actinic keratoses. Expert Opin Pharmacother. 2011;12:451-461.
47. Feldman SR, Fleischer AB Jr, Williford PM, et al. Destructive procedures are the standard of care for treatment of actinic keratoses. J Am Acad Dermatol. 1999;40:43-47.
48. Halpern AC, Hanson LJ. Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians. Int J Dermatol. 2004;43:638-642.
49. Krawtchenko N, Roewert-Huber J, Ulrich M, et al. A randomized study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol. 2007;157(suppl 2):34-40.
50. Thai KE, Fergin P, Freeman M, et al. A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol. 2004;43:687-692.
51. Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat. 2003;14:99-106.
52. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinatecompared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol. 2002;47:258-262.
53. Jorizzo J, Weiss J, Furst K, et al. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial. Arch Dermatol. 2004;140:813-816.
54. Tan JK, Thomas DR, Poulin Y, et al. Efficacy of imiquimod as an adjunct to cryotherapy for actinic keratoses. J Cutan Med Surg. 2007;11:195-201.